Project Grant 2051411
Award Date
9/1/21
Completion Date
2/28/22
Dollars Obligated
$256K
Federal Agency
Division of Industrial Innovation
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55411, USA
Similar Awards
The National Science Foundation (NSF) awarded a $878,296 Cooperative Agreement to Surfplasma Inc., a minority-owned small business based in Gainesville, FL, to develop a rapid, low-temperature plasma prototype for disinfecting personal protective equipment (PPE), medical devices, food products and other materials from pathogens like COVID-19. The project, funded under NSF's Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to deliver a market-ready sterilization solution...
The National Science Foundation Division of Industrial Innovation awarded MBF Therapeutics Inc. a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) from January 1, 2022 to December 31, 2022. The grant funds the development of a protective T cell vaccine for SARS CoV-2 (COVID-19). The Engineering program supports innovation, creativity and excellence in engineering research and education to improve quality of life and economic strength. This award furthers those...
The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...
This Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $331,189 to develop a new, affordable technology for virus detection. The project integrates protein engineering and electrochemical biosensors to create a portable, room-temperature stable platform for virus testing in resource-limited environments. Key innovations include the use of stable enzymes that can be stored at ambient temperatures,...
Nanored LLC received a $246,731 National Science Foundation Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to support the development of a novel SARS-CoV-2 virus-like particle optimized to deliver shRNA therapeutics from March 1, 2021 through April 30, 2022. The grant aims to prevent and treat COVID-19 infection through a delivery method utilizing virus-like particles to transport self-amplifying short hairpin RNA molecules into cells. The funding will...
The National Science Foundation awarded a $255,961 Small Business Technology Transfer Phase I Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to Rush River Research Corp. The grant aims to develop a low-cost, automated receptacle for rapid point-of-care sterilization of personal protective equipment, such as filtering facepiece respirators, for frontline healthcare workers during the COVID-19 pandemic. Specifically, the company will construct and...
This $255,966 National Science Foundation Technology, Innovation, and Partnerships award to Nano-Product Engineering, LLC will support the development of an antiviral/antimicrobial micropowder for application to personal protective equipment and respiratory equipment surfaces. The award period is from September 15, 2022 through May 31, 2023. The project aims to improve the protective properties of commonly used PPE and respiratory equipment, which typically only provides passive protection and...
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to White Rock Therapeutics under the Engineering federal grant program (CFDA 47.041). The grant will support development of an ACE2 decoy as a pan-coronavirus therapeutic from January 2022 to December 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award will fund initial research...
Altigg Therapeutics, Inc. was awarded a $255,595 Small Business Technology Transfer (STTR) Phase I Project Grant from the National Science Foundation's Engineering program (CFDA 47.041) for the period of April 1, 2021 through March 31, 2022. Under this award, Altigg Therapeutics will develop a platform for the rapid discovery of human antibodies as therapeutics for infectious diseases such as COVID-19. The NSF Engineering program seeks to improve quality of life and economic strength through...
This Project Grant from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provided $255,943 to Athem LLC from February 15, 2021 through March 31, 2022. The grant funded the development of a medical device to isolate and purify therapeutic antibodies from recovered COVID-19 donors. The NSF Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award aimed to advance those goals by...